Poster presentations

Tuesday, 2 November 2021

Leishmaniasis infection among the migrant population of Europe: a systematic review
Dr Melanie Etti, St. George’s University of London, UK
Epidemiology of Visceral Leishmaniasis in Kenya, June-December 2020
Dr Paul Kibati, Ministry of Health, Kenya
The utility of the Loop-Mediated Isothermal Amplification Assay for Monitoring Anti-leishmanial Treatment Efficacy in visceral leishmaniasis
Dawit Gebreegzabher Hagos, Mekelle University, Ethiopia
The Translational Prospective of secretory proteins of Mycobacterium tuberculosis encapsulated in Bio-polymeric nanoparticles: An Interplay of Immune Response
Dr Ramendra Pati Pandey, SRM University, India
Development of a Tropically Stable, Novel Oral Formulation of Amphotericin B to Treat Visceral Leishmaniasis
Dr Kishor M. Wasan, University of British Columbia, Canada

Wednesday, 3 November 2021

Building capacity for Immunological Research and flow cytometry expertise in Uganda
Alice Bayiyana, Makerere University, Uganda
Multiplexed qPCR panels to differentiate clinically relevant Leishmania species utilising bisulphite conversion technology
Ineka Gow, University of Technology Sydney, Australia
Analysis of changes in mitochondrial membrane potential after Photodynamic Therapy in Leishmania promastigotes
Luciana Maria Cortez Marcolino, University of Vale of Paraiba, Brazil
Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin
Aschalew Tamiru, University of Gondar Leishmaniasis Research and Treatment Center, Ethiopia
Loop-Mediated Isothermal Amplification Assay for the Diagnosis of Leishmaniasis
Dawit Gebreegzabher Hagos, Mekelle University College of Health Sciences, Ethiopia
Soluble adenylate cyclase of Leishmania donovani (LdHemAC) induced cyclic AMP upregulates Nrf2 mediated Heme oxygenase-1 expression promotes its intra-macrophages survival against oxidative stress
Manjay Kumar, ICMR-RMRIMS, India